KRBPKiromic BioPharmaKRBP info
$1.69info0.00%24h
Global rank35976
Market cap$2.13M
Change 7d-12.89%
YTD Performance70.71%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Kiromic BioPharma (KRBP) Stock Overview

    Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The company develops ALEXIS-ISO-1, an allogeneic GDT therapy product that targets an isoform of mesothelin; and ALEXIS-PRO-1, an allogeneic GDT therapy product that targets PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, as well as a research and development collaboration agreement with Molipharma, S.R.L. The company also has strategic alliance agreement with Leon Office (H.K.) Ltd. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.

    KRBP Stock Information

    Symbol
    KRBP
    Address
    7707 Fannin StreetHouston, TX 77054United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.kiromic.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    832-968-4888

    Kiromic BioPharma (KRBP) Price Chart

    -
    Value:-

    Kiromic BioPharma Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.69
    N/A
    Market Cap
    $2.13M
    N/A
    Shares Outstanding
    1.26M
    N/A
    Employees
    31.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org